- Home
- SNTI vs NDLS Comparison
SNTI vs NDLS Comparison
Compare SNTI & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- NDLS
- Stock Information
- Founded
- SNTI 2016
- NDLS 1995
- Country
- SNTI United States
- NDLS United States
- Employees
- SNTI N/A
- NDLS N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- NDLS Restaurants
- Sector
- SNTI Health Care
- NDLS Consumer Discretionary
- Exchange
- SNTI Nasdaq
- NDLS Nasdaq
- Market Cap
- SNTI 39.6M
- NDLS 33.2M
- IPO Year
- SNTI N/A
- NDLS 2013
- Fundamental
- Price
- SNTI $1.56
- NDLS $0.71
- Analyst Decision
- SNTI Strong Buy
- NDLS Buy
- Analyst Count
- SNTI 2
- NDLS 2
- Target Price
- SNTI $8.50
- NDLS $3.00
- AVG Volume (30 Days)
- SNTI 107.2K
- NDLS 208.1K
- Earning Date
- SNTI 08-07-2025
- NDLS 08-13-2025
- Dividend Yield
- SNTI N/A
- NDLS N/A
- EPS Growth
- SNTI N/A
- NDLS N/A
- EPS
- SNTI N/A
- NDLS N/A
- Revenue
- SNTI N/A
- NDLS $494,752,000.00
- Revenue This Year
- SNTI N/A
- NDLS $1.19
- Revenue Next Year
- SNTI $150.00
- NDLS N/A
- P/E Ratio
- SNTI N/A
- NDLS N/A
- Revenue Growth
- SNTI N/A
- NDLS N/A
- 52 Week Low
- SNTI $1.46
- NDLS $0.55
- 52 Week High
- SNTI $16.94
- NDLS $1.74
- Technical
- Relative Strength Index (RSI)
- SNTI 37.24
- NDLS 41.10
- Support Level
- SNTI $1.52
- NDLS $0.70
- Resistance Level
- SNTI $1.65
- NDLS $0.76
- Average True Range (ATR)
- SNTI 0.10
- NDLS 0.08
- MACD
- SNTI 0.03
- NDLS -0.02
- Stochastic Oscillator
- SNTI 50.00
- NDLS 9.59
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.